|
JMJD1C expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.16640030967119E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.32080002490653E-09 |
| Normal-vs-Stage2 |
9.21469567316535E-11 |
| Normal-vs-Stage3 |
2.48969733718241E-11 |
| Normal-vs-Stage4 |
2.17420526027468E-11 |
| Stage1-vs-Stage2 |
8.089700E-02 |
| Stage1-vs-Stage3 |
3.879700E-02 |
| Stage1-vs-Stage4 |
5.016200E-02 |
| Stage2-vs-Stage3 |
8.761200E-01 |
| Stage2-vs-Stage4 |
8.936000E-01 |
| Stage3-vs-Stage4 |
7.640400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.73510161372815E-11 |
| Normal-vs-AfricanAmerican |
2.226300E-04 |
| Normal-vs-Asian |
2.29279999985899E-07 |
| Caucasian-vs-AfricanAmerican |
3.352400E-01 |
| Caucasian-vs-Asian |
1.717560E-01 |
| AfricanAmerican-vs-Asian |
9.780800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.91799995277842E-09 |
| Normal-vs-Female |
6.10670403133895E-11 |
| Male-vs-Female |
2.294400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.83069997944574E-09 |
| Normal-vs-Age(41-60Yrs) |
7.22619741821973E-11 |
| Normal-vs-Age(61-80Yrs) |
9.37960820124317E-12 |
| Normal-vs-Age(81-100Yrs) |
2.336400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.130230E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.734090E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.389400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.694200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.710000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.577200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.820300E-02 |
| Classical-VS-Follicular |
2.516000E-01 |
| Classical-VS-Other |
4.651600E-01 |
| Classical-VS-Normal |
5.20999998698812E-09 |
| Tall-VS-Follicular |
1.769760E-01 |
| Tall-VS-Other |
6.210000E-02 |
| Tall-VS-Normal |
1.78980053000544E-10 |
| Follicular-VS-Other |
3.378400E-01 |
| Follicular-VS-Normal |
1.04059982852789E-10 |
| Other-VS-Normal |
4.407700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.58349999779261E-11 |
| Normal-vs-N1 |
4.00720001625388E-09 |
| N0-vs-N1 |
5.800000E-01 |
|
|
